Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curcuma + phospholipids refers to a class of dietary supplement formulations in which **curcumin** (the principal active component of the spice turmeric, *Curcuma longa*) is complexed or combined with **phospholipids** (such as phosphatidylcholine or soy lecithin) to significantly enhance curcumin's bioavailability and cellular uptake. Curcumin acts as an anti-inflammatory and antioxidant agent by modulating multiple cell signaling pathways, including nuclear factor kappa B (NF-κB), cyclooxygenase-2 (COX-2), and various cytokines. The phospholipids act as absorption enhancers, allowing for better penetration of curcumin through cell membranes and increased systemic presence. Such formulations are primarily marketed for support of joints, bones, gastrointestinal health, and immune system function[1][2][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on curcuma + phospholipids.